Private Markets
We look to invest in lower middle-market companies partnering with exceptional founders and teams.
We are not constrained by fixed investment holding periods. We maintain a flexible approach when it comes to structuring and are receptive to taking equity or credit positions in the capital structure. Our ultimate goal is to maximize long-term value without undue risk of loss. We invest directly as well as through fund commitments and co-investments.
In private lending, Helix seeks to partner with borrowers, providing the support they require to realize their goals. We work in areas that are not well served by mainstream lenders.
By listening to a borrower’s needs, we can find solutions to fill in a capital structure. While solid collateral is core to our underwriting process, we do not fund “bridges-to-nowhere” or loan-to-own. Planned and expected cash flows must support a credit in their own right.
Please note that this list is provided for information only and the views we express on holdings do not constitute Investment Recommendations and must not be viewed as such.
Private Equity firm aiming to transform the delivery of healthcare to underserved and vulnerable communities by investing in growth oriented, patient-focused companies.
Digitally native health and wellness brand operating in the premium vitamins, minerals, and supplements (“VMS”) industry.
Health and wellness company based in Florida, United States, that manufactures and markets leading dietary supplement brands.
Sold to The Clorox Company in 2018.
Provider of testing, inspection and certification services for UK buildings.
Majority sold to Warburg Pincus in 2021.
World-leading provider of drug delivery solutions, SHL designs, develops, and manufactures advanced drug delivery devices such as autoinjectors, pen injectors, and innovative specialty delivery systems for large-volume and high-viscosity formulations
Market leading investment firm investing in invest in enterprise software, data and technology companies through private equity, permanent capital, credit and public equity investment strategies.
Contact Us